Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 590 JPY -2.24% Market Closed
Market Cap: 132.2B JPY

Torii Pharmaceutical Co Ltd
Other Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torii Pharmaceutical Co Ltd
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Other Items
-ÂĄ3.4B
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Items
-ÂĄ89.4B
CAGR 3-Years
N/A
CAGR 5-Years
35%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Other Items
ÂĄ477.9B
CAGR 3-Years
69%
CAGR 5-Years
64%
CAGR 10-Years
24%
Otsuka Holdings Co Ltd
TSE:4578
Other Items
-ÂĄ136.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-11%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Items
-ÂĄ102.9B
CAGR 3-Years
-31%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Other Items
-ÂĄ43.2B
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
N/A

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
129B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
4 709.68 JPY
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Torii Pharmaceutical Co Ltd's Other Items?
Other Items
-3.4B JPY

Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Other Items amounts to -3.4B JPY.

What is Torii Pharmaceutical Co Ltd's Other Items growth rate?
Other Items CAGR 3Y
-44%

Over the last year, the Other Items growth was 5%. The average annual Other Items growth rates for Torii Pharmaceutical Co Ltd have been -44% over the past three years .

Back to Top